| Gregory James Roehrig, MD | |
|
2315 Route 34, Manasquan, NJ 08736-1423 | |
| (732) 974-0404 | |
| (732) 449-4271 |
| Full Name | Gregory James Roehrig |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 21 Years |
| Location | 2315 Route 34, Manasquan, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477562890 | NPI | - | NPPES |
| P00768642 | Other | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 25MA08577000 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hackensack Meridian Health At Home Ocean County | Brick, NJ | Home health agency |
| Hackensack Meridian Health At Home Monmouth County | Neptune, NJ | Home health agency |
| Jersey Shore University Medical Center | Neptune, NJ | Hospital |
| Ocean Medical Center | Brick, NJ | Hospital |
| Centrastate Medical Center | Freehold, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthonj Llc | 6800225178 | 276 |
News Archive
The combination of Biothera's experimental drug Imprime PGG® and Erbitux® (cetuximab) doubled the historical overall response rate and the time to progression of second- and third-line metastatic colorectal cancer patients treated with Erbitux monotherapy. The data was released last weekend at the 13th World Congress on Gastrointestinal Cancer at the European Society for Medical Oncology (ESMO).
Most of the 600,000 Americans with hypertrophic cardiomyopathy (HCM) - a genetic heart muscle disease - can live normal life spans, according to the first science-based guideline for diagnosing and treating this disorder.
Researchers from the University of Nebraska-Lincoln, Harvard Medical School and MIT have designed a smart bandage that could eventually heal chronic wounds or battlefield injuries with every fiber of its being.
Abbott will voluntarily withdraw sibutramine from the Canadian market after discussion with Health Canada. Sibutramine is marketed by Abbott in Canada as Meridia.
› Verified 4 days ago
| Entity Name | Orthopaedic Institute Of Central Jersey |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043286735 PECOS PAC ID: 1658366513 Enrollment ID: O20040419001414 |
News Archive
The combination of Biothera's experimental drug Imprime PGG® and Erbitux® (cetuximab) doubled the historical overall response rate and the time to progression of second- and third-line metastatic colorectal cancer patients treated with Erbitux monotherapy. The data was released last weekend at the 13th World Congress on Gastrointestinal Cancer at the European Society for Medical Oncology (ESMO).
Most of the 600,000 Americans with hypertrophic cardiomyopathy (HCM) - a genetic heart muscle disease - can live normal life spans, according to the first science-based guideline for diagnosing and treating this disorder.
Researchers from the University of Nebraska-Lincoln, Harvard Medical School and MIT have designed a smart bandage that could eventually heal chronic wounds or battlefield injuries with every fiber of its being.
Abbott will voluntarily withdraw sibutramine from the Canadian market after discussion with Health Canada. Sibutramine is marketed by Abbott in Canada as Meridia.
› Verified 4 days ago
| Entity Name | Orthonj Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720557432 PECOS PAC ID: 6800225178 Enrollment ID: O20200408000333 |
News Archive
The combination of Biothera's experimental drug Imprime PGG® and Erbitux® (cetuximab) doubled the historical overall response rate and the time to progression of second- and third-line metastatic colorectal cancer patients treated with Erbitux monotherapy. The data was released last weekend at the 13th World Congress on Gastrointestinal Cancer at the European Society for Medical Oncology (ESMO).
Most of the 600,000 Americans with hypertrophic cardiomyopathy (HCM) - a genetic heart muscle disease - can live normal life spans, according to the first science-based guideline for diagnosing and treating this disorder.
Researchers from the University of Nebraska-Lincoln, Harvard Medical School and MIT have designed a smart bandage that could eventually heal chronic wounds or battlefield injuries with every fiber of its being.
Abbott will voluntarily withdraw sibutramine from the Canadian market after discussion with Health Canada. Sibutramine is marketed by Abbott in Canada as Meridia.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory James Roehrig, MD 2315 Route 34, Manasquan, NJ 08736-1423 Ph: (732) 974-0404 | Gregory James Roehrig, MD 2315 Route 34, Manasquan, NJ 08736-1423 Ph: (732) 974-0404 |
News Archive
The combination of Biothera's experimental drug Imprime PGG® and Erbitux® (cetuximab) doubled the historical overall response rate and the time to progression of second- and third-line metastatic colorectal cancer patients treated with Erbitux monotherapy. The data was released last weekend at the 13th World Congress on Gastrointestinal Cancer at the European Society for Medical Oncology (ESMO).
Most of the 600,000 Americans with hypertrophic cardiomyopathy (HCM) - a genetic heart muscle disease - can live normal life spans, according to the first science-based guideline for diagnosing and treating this disorder.
Researchers from the University of Nebraska-Lincoln, Harvard Medical School and MIT have designed a smart bandage that could eventually heal chronic wounds or battlefield injuries with every fiber of its being.
Abbott will voluntarily withdraw sibutramine from the Canadian market after discussion with Health Canada. Sibutramine is marketed by Abbott in Canada as Meridia.
› Verified 4 days ago
Mark M Seckler, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2444 Highway 34, Manasquan, NJ 08736 Phone: 732-528-4370 Fax: 732-528-4525 | |
Ahmed Siddiqi, D.O Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2315 Route 34, Manasquan, NJ 08736 Phone: 732-974-0404 Fax: 732-449-4271 | |
Dr. John M Tozzi, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2315 Rt 34 So, Ste D, Manasquan, NJ 08736 Phone: 732-974-0404 Fax: 732-449-4271 | |
Dr. Clint C Ferenz, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2315 Rt 34 So, Ste D, Manasquan, NJ 08736 Phone: 732-974-0404 Fax: 732-449-4271 | |
Dr. Ramil S Bhatnagar, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2315 Rt 34 So, Ste D, Manasquan, NJ 08736 Phone: 732-974-0404 Fax: 732-449-4271 | |
Dr. Nicholas Albert Jarmon, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2315 Route 34, Manasquan, NJ 08736 Phone: 732-974-0404 | |
Dr. Michael A Sclafani, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2315 Rt 35 So, Ste D, Manasquan, NJ 08736 Phone: 732-974-0404 Fax: 732-449-4271 |